6.79MMarket Cap-462P/E (TTM)
0.770High0.716Low175.27KVolume0.716Open0.733Pre Close130.12KTurnover6.61%Turnover RatioLossP/E (Static)8.93MShares106.32452wk High1.85P/B2.02MFloat Cap0.30252wk Low--Dividend TTM2.65MShs Float28282.800Historical High--Div YieldTTM7.37%Amplitude0.301Historical Low0.742Avg Price1Lot Size
GRI Bio Stock Forum
GRI Bio Showcases GRI-0621’s Potential to Reduce Inflammation, Type 1 Cytokines and Reduce Hepatic Fibrosis in Idiopathic Pulmonary Fibrosis (IPF)
GRI Bio presented positive preclinical data for GRI-0621, its lead program targeting Idiopathic Pulmonary Fibrosis (IPF), at the 8th Annual Antifibrotic Drug Development Summit. The data showed that GRI-0621 reduces inflammation and fibrotic drivers in IPF. Key findings demonstrated increased iNKT cell activity correlating with f...
1 MINUTE AGO, 8:45 AM EST
VIA GLOBENEWSWIRE
Workshop, poster and oral presentation of data given as part of the 8th Annual Antifibrotic Drug Development (AFDD) Summit
Data demonstrate that NKT cells are activated in airways in IPF patients and inhibition of iNKT cell activity with GRI-0621 ameliorates pulmonary fibrosis in a pr...
RSI is what, volume is shit lol
No comment yet